Studies have demonstrated that NRP-1 knockdown increases chemosensitivity towards chemotherapeutic drugs in a variety of cancer cells, including pancreatic cancer cells [61, 83]. The gene discussed is NRP1; the disease is familial pancreatic carcinoma.